The global submucosal lifting agent market is on a trajectory for remarkable growth, with projections indicating a compound annual growth rate (CAGR) of 6.9% over the next decade. The market is expected to rise from USD 114.2 million in 2023 to an impressive USD 222.6 million by 2033.
The growth momentum follows a robust year-over-year expansion rate of 6.8% in 2023, building on the end-of-year market valuation of USD 106.9 million in 2022. This positive trend underscores the increasing demand for submucosal lifting agents, driven by their critical role in enhancing the efficacy and safety of medical procedures.
Submucosal lifting agents are integral to modern medical practices, particularly in endoscopic procedures. These agents are injected into the submucosal layer to create a separation between the mucous membrane and the underlying tissue. This technique improves visibility and maneuverability, leading to more efficient and safer procedures.
Empower Your Decisions with Data-Driven Insights from Our Sample Report – Get It Now
Commonly used submucosal lifting agents include sodium hyaluronate, cellulose, absorbable starch polymers, and poloxamers. These agents are favored for their biocompatibility and their ability to form a temporary cushion, thereby enhancing the endoscopic process.
The growing demand for minimally invasive surgical techniques and the increasing prevalence of gastrointestinal disorders are key drivers behind the market’s expansion. Advances in medical technology and the continuous development of new and improved submucosal lifting agents are expected to further propel market growth.
Key Takeaways from Market Study:
- By ingredients, sodium hyaluronate segment contributed around USD 30.4 million in 2022. Sodium hyaluronate, a natural glycosaminoglycan, aids wound healing, inflammation, and cell interactions, making it vital in submucosal lifting agents.
- By application, early-stage cancer contributed around USD 34.9 million in 2022. Submucosal lifting agents aid in endoscopic resection of early-stage gastrointestinal cancers, cushioning lesions and reducing procedure times for effective removal.
- By end user, hospitals contributed around USD 39.5 million in 2022. Due to the demand for surgical procedures and the use of sophisticated medical facilities, hospitals dominate the market for submucosal lifting agent.
- By region, North America held the dominant share in the world in 2022 contributing around USD 44.6 million. The North America region dominates the submucosal lifting agent market due to advanced healthcare infrastructure and high adoption rates.
“The market for precise, minimally invasive endoscopic operations is being shaped by cutting-edge developments in submucosal lifting agents” says an analyst of Future Market Insights.
Market Competition:
Steris and Ovesco Endoscopy AG are two of the key players leading in the postoperative panniculus retractor market. In order to gain a larger market share, these companies participate in acquisitions and launch new products that provide affordability, convenience, and effectiveness.
- In May 2023, Ovesco Endoscopy AG has acquired distribution from Fides Medical BV, allowing Ovesco to sell products directly in Belgium and Luxemburg from June 2023. This move aligns with Ovesco’s strategy to match Fides’ high-quality service to local hospitals, while also fulfilling corporate responsibility.
- In April 2023, Steris’ ASCENDO™ Submucosal Lifting Agent offers quality endoscopic lift, optimal height and duration, and a prefilled syringe for easy, safe resection procedures. It is biocompatible and sterile, making it a convenient and effective solution for endoscopic procedures.
Transform Your Business Access the Comprehensive Report Now
Key Companies Profiled:
- Laborie
- STERIS
- Olympus America
- Medtronic
- Boston Scientific Corporation
- Omnimed Ltd™
- COSMO PHARMACEUTICALS
- Micro-Tech Endoscopy
- Ovesco Endoscopy AG
Key Market Segments Covered in Submucosal Lifting Agent Industry Research:
By Ingredient:
- Poloxamer 188 and Polyoxyl-15-hydroxystearate
- Gellan gum and Polysaccharide
- Sodium Hyaluronate
- Cellulose
- Absorbable Starch Polymers
- Poloxamers
By Application:
- Polyps
- Adenomas
- Early-stage Cancers
- Gastrointestinal Mucosal Lesions
- Others
By End User:
- Hospitals
- Specialty Clinics
- Surgical Centers
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube